Page last updated: 2024-11-12

neotuberostemonine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

neotuberostemonine: from Stemona collinsae; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
StemonagenusA plant genus of the family Stemonaceae. Members contain STILBENES and phenyl BENZOFURANS.[MeSH]StemonaceaeA small plant family of the order Liliales, subclass Liliidae, class Liliopsida (monocotyledons).[MeSH]

Cross-References

ID SourceID
PubMed CID11667940
CHEMBL ID479493
CHEBI ID69386
SCHEMBL ID19197265
MeSH IDM0442727

Synonyms (14)

Synonym
chebi:69386 ,
neotuberostemonine
CHEMBL479493
143120-46-1
AC-34908
SCHEMBL19197265
AKOS032948153
Q27137725
HY-N3196
CS-0023550
(1s,3s,9r,10r,11r,14s,15r,16r)-10-ethyl-14-methyl-3-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-12-oxa-4-azatetracyclo[7.6.1.04,16.011,15]hexadecan-13-one
MS-26085
DTXSID501316122
E80776

Research Excerpts

Overview

Neotuberostemonine is a potent antitussive alkaloid extracted from Stemona tuberosa.

ExcerptReferenceRelevance
"Neotuberostemonine (NTS) is an active compound isolated from Stemona tuberosa Lour."( Neotuberostemonine inhibits osteoclastogenesis via blockade of NF-κB pathway.
Lee, KY; Park, B; Yun, J, 2019
)
2.68
"Neotuberostemonine is a potent antitussive alkaloid extracted from Stemona tuberosa. "( Pharmacokinetics, biodistribution and excretion studies of neotuberostemonine, a major bioactive alkaloid of Stemona tuberosa.
Han, D; Ou, L; Tong, Y; Wu, Y; Xu, X; Zhang, C; Zhang, M, 2016
)
2.12

Pharmacokinetics

ExcerptReferenceRelevance
" In this work, plasma pharmacokinetic and biodistribution characteristics of the three alkaloids after oral administration of Stemonae Radix are investigated using a rapid and sensitive UPLC-Q-TOF-HDMS method."( Ultra-performance liquid-chromatography with tandem mass spectrometry performing pharmacokinetic and biodistribution studies of croomine, neotuberostemonine and tuberostemonine alkaloids absorbed in the rat plasma after oral administration of Stemonae Rad
Dong, W; Sun, H; Wang, W; Wang, X; Zhang, A, 2012
)
0.58
" The present study was aimed to investigate the pharmacokinetic parameters of neotuberostemonine by developing an ultra-high performance liquid chromatography-tandem mass spectrometry method."( Pharmacokinetics, biodistribution and excretion studies of neotuberostemonine, a major bioactive alkaloid of Stemona tuberosa.
Han, D; Ou, L; Tong, Y; Wu, Y; Xu, X; Zhang, C; Zhang, M, 2016
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
alkaloidAny of the naturally occurring, basic nitrogen compounds (mostly heterocyclic) occurring mostly in the plant kingdom, but also found in bacteria, fungi, and animals. By extension, certain neutral compounds biogenetically related to basic alkaloids are also classed as alkaloids. Amino acids, peptides, proteins, nucleotides, nucleic acids, amino sugars and antibiotics are not normally regarded as alkaloids. Compounds in which the nitrogen is exocyclic (dopamine, mescaline, serotonin, etc.) are usually classed as amines rather than alkaloids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID377037Ex vivo inhibition of leukotriene formation in calcium ionophore activated human neutrophilic granulocyte at 50 uM by ELISA2005Journal of natural products, Jan, Volume: 68, Issue:1
Inhibition of leukotriene biosynthesis by stilbenoids from Stemona species.
AID377748Antitussive activity in ip dosed Dunkin-Hartley guinea pig assessed as inhibition of citric acid-induced cough administered 30 mins before citric acid challenge2006Journal of natural products, Jul, Volume: 69, Issue:7
Stemoninines from the roots of Stemona tuberosa.
AID377036Ex vivo inhibition of leukotriene formation in calcium ionophore activated human neutrophilic granulocyte by ELISA2005Journal of natural products, Jan, Volume: 68, Issue:1
Inhibition of leukotriene biosynthesis by stilbenoids from Stemona species.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (40.00)29.6817
2010's8 (53.33)24.3611
2020's1 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]